Azoles

Medchemexpress LLC 4-(Benzo[d]oxazol-2-yl)aniline | 20934-81-0 | MFCD00453046 | 99.9% | 210.24 | C13H10N2O | 25 G

4-(Benzo[d]oxazol-2-yl)aniline (CAS 20934-81-0) is a small-molecule research compound reported to have antitumor activity, including inhibitory effects against mammary carcinoma cell lines. The product is analytically characterized with HPLC purity reported at 99.93% and has defined storage recommendations to preserve stability.

• High HPLC purity (99.93%) for reliable analytical work.
• Reported antitumor activity against mammary carcinoma cell lines.
• Molecular formula C13H10N2O; molecular weight 210.24.
• Recommended storage: 4°C, protect from light; in solvent: -80°C (up to 6 months), -20°C (1 month).
• Suitable as a research reagent for oncology and related studies.

Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 | C17H23N3O | 25 MG

PSN 375963 is a small-molecule agonist of the G protein-coupled receptor GPR119 used as a research tool to study GPR119-mediated signaling and metabolic effects. It is supplied as a characterized solid for in vitro and preclinical investigations.

• Potent GPR119 agonist with human EC50 8.4 μM and mouse EC50 7.9 μM.
• Chemical formula C17H23N3O; molecular weight 285.38 g/mol.
• Solid, white to off-white appearance, suitable for assay use.
• High purity (≈99.96%) by HPLC.
• Recommended storage: powder -20°C (long term) or 4°C (short term); in solvent -80°C.

Medchemexpress LLC Phthalazinone pyrazole | 880487-62-7 | MFCD28399120 | 98.0% | 317.34 | C18H15N5O | 5MG

Phthalazinone pyrazole is a small-molecule Aurora-A kinase inhibitor used in research on cell cycle regulation, apoptosis, and mitosis. It is supplied as a solid and as a DMSO solution for biochemical and cellular assays.

• Potent Aurora-A kinase inhibitor for research use.
• Molecular formula C18H15N5O, molecular weight 317.34 g·mol⁻¹.
• Purity ≥98.0% by HPLC.
• Available as solid (5 mg-100 mg) and solution (10 mM in DMSO, 1 mL).
• Store at 4°C, protect from light; in solvent: -80°C (6 months), -20°C (1 month).
• Provided with datasheet, SDS, and COA for characterization.

Medchemexpress LLC 6-bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl] | 1095382-05-0 | ≥98.0% | 551.48 g·mol⁻¹ | C26H31BrN8O | 5 MG

A potent, orally available Aurora kinase inhibitor active against Aurora A, B, and C that displays antiproliferative activity in multiple tumor cell lines. The compound is supplied as a powder for research use and has documented solubility and storage recommendations for both powder and solution forms.

• Potent inhibition of Aurora A, B, and C with IC50s of 15, 25, and 19 nM.
• Orally bioavailable compound showing antiproliferative activity in tumor cell lines.
• Supplied as a powder with high purity (≥98% by HPLC).
• Molecular weight 551.48 g·mol⁻¹ and formula C26H31BrN8O.
• Soluble in DMSO (16.67 mg/mL) and compatible with common vehicle formulations.
• Recommended storage: powder at -20°C (3 years) or 4°C (2 years); in solvent at -80°C (2 years).